Will ClariPi's ClariACE product receive FDA 510K clearance by December 1, 2023?
10
Ṁ210Ṁ2.2kresolved Dec 19
Resolved
NO1H
6H
1D
1W
1M
ALL
ClariACE is an Augmented Contrast Enhancing solution for low-dose CECT (Contrast-enhanced computed tomography) images.
ClariPi has three AI products that have already received FDA clearance. This market resolves YES if ClariACE receives FDA 510K clearance by December 1, 2023.
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ190 | |
| 2 | Ṁ12 | |
| 3 | Ṁ4 | |
| 4 | Ṁ1 | |
| 5 | Ṁ0 |
Sort by:
